Song Wei, Shu-Hao Li, Bo-Ran Lv, Bai-Yu Liu, Hua Wang, Cheng Hu
{"title":"Prediction of postoperative SIRS risk factors in MetS patients undergoing PCNL.","authors":"Song Wei, Shu-Hao Li, Bo-Ran Lv, Bai-Yu Liu, Hua Wang, Cheng Hu","doi":"10.1007/s00240-025-01806-0","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to identify preoperative risk factors for systemic inflammatory response syndrome (SIRS) in patients with metabolic syndrome (MetS) undergoing percutaneous nephrolithotomy (PCNL) and to develop a predictive nomogram for individualized risk stratification. A retrospective analysis was conducted on 245 MetS patients who underwent PCNL between January 2021 and December 2024, among whom 27.8% developed postoperative SIRS. Patients were randomly assigned to training and validation cohorts in a 7:3 ratio. Least absolute shrinkage and selection operator (LASSO) regression was initially applied to select candidate predictors, followed by univariate and multivariate logistic regression analyses to identify independent risk factors. A nomogram was subsequently constructed based on the significant variables and evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Multivariate analysis identified five independent predictors of postoperative SIRS: higher standard deviation of stone density, reduced renal parenchymal thickness, increased lateral and posterior perirenal fat thicknesses, and the presence of staghorn calculi (P < 0.05). The nomogram demonstrated good discriminative ability, with an area under the ROC curve (AUC) of 0.888 (95% CI: 0.834-0.942) in the training cohort and 0.882 (95% CI: 0.802-0.962) in the validation cohort. The calibration curve and the Hosmer-Lemeshow test (P = 0.1485) indicated good model calibration and fit. DCA further confirmed the clinical utility of the model. This nomogram offers a reliable preoperative tool for SIRS risk stratification in MetS patients undergoing PCNL, aiding early intervention and personalized perioperative management.</p>","PeriodicalId":23411,"journal":{"name":"Urolithiasis","volume":"53 1","pages":"135"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12228654/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urolithiasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00240-025-01806-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to identify preoperative risk factors for systemic inflammatory response syndrome (SIRS) in patients with metabolic syndrome (MetS) undergoing percutaneous nephrolithotomy (PCNL) and to develop a predictive nomogram for individualized risk stratification. A retrospective analysis was conducted on 245 MetS patients who underwent PCNL between January 2021 and December 2024, among whom 27.8% developed postoperative SIRS. Patients were randomly assigned to training and validation cohorts in a 7:3 ratio. Least absolute shrinkage and selection operator (LASSO) regression was initially applied to select candidate predictors, followed by univariate and multivariate logistic regression analyses to identify independent risk factors. A nomogram was subsequently constructed based on the significant variables and evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Multivariate analysis identified five independent predictors of postoperative SIRS: higher standard deviation of stone density, reduced renal parenchymal thickness, increased lateral and posterior perirenal fat thicknesses, and the presence of staghorn calculi (P < 0.05). The nomogram demonstrated good discriminative ability, with an area under the ROC curve (AUC) of 0.888 (95% CI: 0.834-0.942) in the training cohort and 0.882 (95% CI: 0.802-0.962) in the validation cohort. The calibration curve and the Hosmer-Lemeshow test (P = 0.1485) indicated good model calibration and fit. DCA further confirmed the clinical utility of the model. This nomogram offers a reliable preoperative tool for SIRS risk stratification in MetS patients undergoing PCNL, aiding early intervention and personalized perioperative management.
期刊介绍:
Official Journal of the International Urolithiasis Society
The journal aims to publish original articles in the fields of clinical and experimental investigation only within the sphere of urolithiasis and its related areas of research. The journal covers all aspects of urolithiasis research including the diagnosis, epidemiology, pathogenesis, genetics, clinical biochemistry, open and non-invasive surgical intervention, nephrological investigation, chemistry and prophylaxis of the disorder. The Editor welcomes contributions on topics of interest to urologists, nephrologists, radiologists, clinical biochemists, epidemiologists, nutritionists, basic scientists and nurses working in that field.
Contributions may be submitted as full-length articles or as rapid communications in the form of Letters to the Editor. Articles should be original and should contain important new findings from carefully conducted studies designed to produce statistically significant data. Please note that we no longer publish articles classified as Case Reports. Editorials and review articles may be published by invitation from the Editorial Board. All submissions are peer-reviewed. Through an electronic system for the submission and review of manuscripts, the Editor and Associate Editors aim to make publication accessible as quickly as possible to a large number of readers throughout the world.